Datopotamab deruxtecan Uses, Dosage, Side Effects and more
Datopotamab deruxtecan is under investigation in clinical trial NCT04656652 (Study of DS-1062A Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-LUNG01)).
| Trade Name | Datopotamab deruxtecan |
| Generic | Datopotamab deruxtecan |
| Datopotamab deruxtecan Other Names | Datopotamab deruxtecan |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
